Viatris, Inc. (VTRS)
14.82
+0.01
(+0.07%)
USD |
NASDAQ |
Apr 28, 16:00
14.82
0.00 (0.00%)
Pre-Market: 08:39
Viatris Research and Development Expense (TTM) : 941.10M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.25B |
| Baxter International, Inc. | 503.00M |
| Zimmer Biomet Holdings, Inc. | -- |
| Dentsply Sirona, Inc. | 150.00M |
| Theravance Biopharma, Inc. | 35.79M |